Correlation Between Defence Therapeutics and Microbix Biosystems

Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Microbix Biosystems at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Microbix Biosystems into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Defence Therapeutics and Microbix Biosystems, you can compare the effects of market volatilities on Defence Therapeutics and Microbix Biosystems and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Microbix Biosystems. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Microbix Biosystems.

Diversification Opportunities for Defence Therapeutics and Microbix Biosystems

-0.11

Correlation Coefficient

Defence Therapeutics  Microbix Biosystems

Good diversification

The 3 months correlation between Defence and Microbix is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Microbix Biosystems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbix Biosystems and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Microbix Biosystems. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbix Biosystems has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Microbix Biosystems go up and down completely randomly.

Pair Corralation between Defence Therapeutics and Microbix Biosystems

Assuming the 90 days horizon Defence Therapeutics is expected to generate 2.04 times more return on investment than Microbix Biosystems. However, Defence Therapeutics is 2.04 times more volatile than Microbix Biosystems. It trades about 0.06 of its potential returns per unit of risk. Microbix Biosystems is currently generating about -0.06 per unit of risk. If you would invest  52.00  in Defence Therapeutics on July 26, 2025 and sell it today you would earn a total of  7.00  from holding Defence Therapeutics or generate 13.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Defence Therapeutics  vs.  Microbix Biosystems

Defence Therapeutics

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Defence Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Defence Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Microbix Biosystems

Risk-Adjusted Performance

Weakest

Over the last 90 days Microbix Biosystems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's fundamental drivers remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Defence Therapeutics and Microbix Biosystems

The main advantage of trading using opposite Defence Therapeutics and Microbix Biosystems positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Microbix Biosystems can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will offset losses from the drop in Microbix Biosystems' long position.

The idea behind Defence Therapeutics and Microbix Biosystems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.